Autophagy is deficient in nasal polyps: Implications for the pathogenesis of the disease

International Forum of Allergy and Rhinology

Volumn 5, Issue 2, 2015, Pages 119-123

  Chen, Jeff Yi Fu ^a   Hour, Tzyh Chyuan ^a   Yang, Sheau Fang ^b   Chien, Chen Yu ^b,c,d   Chen, Hau Ren ^e   Tsai, Ke Li ^a   Ko, Jenq Yuh ^f   Wang, Ling Feng ^c,g  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^e NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g KAOHSIUNG MUNICIPAL TA TUNG HOSPITAL   (Taiwan)

Author keywords

Akt; Autophagy; LC3; MTOR; Nasal polyps

Indexed keywords

GREEN FLUORESCENT PROTEIN; LIGHT CHAIN 3 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN; PROTEIN KINASE B; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; LIGHT CHAIN 3, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIGHT CHAIN; NOSE MUCOSA; NOSE POLYP; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE SECTION; WESTERN BLOTTING; CELL CULTURE; METABOLISM; NASAL POLYPS; PATHOPHYSIOLOGY; PHYSIOLOGY;

AUTOPHAGY; BIOLOGICAL MARKERS; CELLS, CULTURED; FIBROBLASTS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NASAL MUCOSA; NASAL POLYPS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84922664358     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21456     Document Type: Article

References (31)

1. Settipane RA, Peters AT, Chiu AG. Chapter 6: nasal polyps. Am J Rhinol Allergy. 2013;27(Suppl 1):S20-S25.
2. Otto BA, Wenzel SE. The role of cytokines in chronic rhinosinusitis with nasal polyps. Curr Opin Otolaryngol Head Neck Surg. 2008;16:270-274.
3. Van Bruaene N, Pérez-Novo CA, Basinski TM, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol. 2008;121:1435-1441, 1441.e1-1441.e3.
4. Figueiredo CR, Silva ID, Weckx LL. Inflammatory genes in nasal polyposis. Curr Opin Otolaryngol Head Neck Surg. 2008;16:18-21.
5. Meyer JE, Bartels J, Görögh T, et al. The role of RANTES in nasal polyposis. Am J Rhinol. 2005;19:15-20.
6. Figueiredo CR, Santos RP, Silva ID, Weckx LL. Microarray cDNA to identify inflammatory genes in nasal polyposis. Am J Rhinol. 2007;21:231-235.
7. Chu HW, Balzar S, Seedorf GJ, et al. Transforming growth factor-beta2 induces bronchial epithelial mucin expression in asthma. Am J Pathol. 2004;165:1097-1106.
8. Fritz SB, Terrell JE, Conner ER, Kukowska-Latallo JF, Baker JR. Nasal mucosal gene expression in patients with allergic rhinitis with and without nasal polyps. J Allergy Clin Immunol. 2003;112:1057-1063.
9. Stankovic KM, Goldsztein H, Reh DD, Platt MP, Metson R. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope. 2008;118:881-889.
10. Liu B, Wu J, Fan J, Peng Y. [Gene expression profiles in human nasal polyps studied by DNA microarray]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008;22:495-497. [Chinese]
11. Wang X, Dong Z, Zhu DD, Guan B. Expression profile of immune-associated genes in nasal polyps. Ann Otol Rhinol Laryngol. 2006;115:450-456.
12. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132:27-42.
13. Fokkens W, Lund V, Mullol J; European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology. 2007;45:97-101.
14. Chen JY, Hung CC, Huang KL, et al. Src family kinases mediate betel quid-induced oral cancer cell motility and could be a biomarker for early invasion in oral squamous cell carcinoma. Neoplasia. 2008;10:1393-1401.
15. Newton JR, Ah-See KW. A review of nasal polyposis. Ther Clin Risk Manag. 2008;4:507-512.
16. Coste A, Lefaucheur JP, Wang QP, et al. Expression of the transforming growth factor beta isoforms in inflammatory cells of nasal polyps. Arch Otolaryngol Head Neck Surg. 1998;124:1361-1366.
17. Lin SK, Shun CT, Kok SH, Wang CC, Hsiao TY, Liu CM. Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis. Arch Otolaryngol Head Neck Surg. 2008;134:522-527.
18. Cho JS, Kang JH, Han IH, Um JY, Lee HM. Activation of TLR4 induces VEGF expression via Akt pathway in nasal polyps. Clin Exp Allergy. 2013;43:1038-1047.
19. Xu G, Xia J, Hua X, et al. Activated mammalian target of rapamycin is associated with T regulatory cell insufficiency in nasal polyps. Respir Res. 2009;10:13.
20. Mainz JG, Koitschev A. Pathogenesis and management of nasal polyposis in cystic fibrosis. Curr Allergy Asthma Rep. 2012;12:163-174.
21. Luciani A, Villella VR, Esposito S, et al. Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition. Nat Cell Biol. 2010;12:863-875.
22. Villella VR, Esposito S, Bruscia EM, et al. Targeting the intracellular environment in cystic fibrosis: restoring autophagy as a novel strategy to circumvent the CFTR defect. Front Pharmacol. 2013;4:1.
23. Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol. 2013;13:722-737.
24. Fabri M, Realegeno SE, Jo EK, Modlin RL. Role of autophagy in the host response to microbial infection and potential for therapy. Curr Opin Immunol. 2011;23:65-70.
25. Vural A, Kehrl JH. Autophagy in macrophages: impacting inflammation and bacterial infection. Scientifica (Cairo). 2014;2014:825463.
26. Alirezaei M, Kemball CC, Whitton JL. Autophagy, inflammation and neurodegenerative disease. Eur J Neuroscience. 2011;33:197-204.
27. de Luca A, Smeekens SP, Casagrande A, et al. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc Natl Acad Sci U S A. 2014;111:3526-3531.
28. Hall LJ, Watson AJ. Role of autophagy in NOD2-induced inflammation in Crohn's disease. Gastroenterology. 2012;142:1032-1034.
29. Nakahira K, Cloonan SM, Mizumura K, Choi AM, Ryter SW. Autophagy: a crucial moderator of redox balance, inflammation, and apoptosis in lung disease. Antiox Redox Signaling. 2014;20:474-494.
30. Chen ML, Yi L, Jin X, et al. Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway. Autophagy. 2013;9:2033-2045.
31. Yoshizaki T, Kusunoki C, Kondo M, et al. Autophagy regulates inflammation in adipocytes. Biochem Biophys Res Commun. 2012;417:352-357.